iohexol has been researched along with Glial Cell Tumors in 5 studies
Iohexol: An effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality.
iohexol : A benzenedicarboxamide compound having N-(2,3-dihydroxypropyl)carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and an N-(2,3-dihydroxypropyl)acetamido group at the 5-position.
Excerpt | Relevance | Reference |
---|---|---|
" The validated method has been successfully applied to a pharmacokinetic study of thermosensitive liposome-encapsulated lomustine containing iohexol and lomustine solution after intravenous administration to C6 glioma rats." | 7.77 | HPLC method validation for the quantification of lomustine to study pharmacokinetics of thermosensitive liposome-encapsulated lomustine containing iohexol for CT imaging in C6 glioma rats. ( Derendorf, H; Gao, J; Li, M; Liu, C; Yu, F; Zeng, Y; Zhang, B; Zhuang, L, 2011) |
" The validated method has been successfully applied to a pharmacokinetic study of thermosensitive liposome-encapsulated lomustine containing iohexol and lomustine solution after intravenous administration to C6 glioma rats." | 3.77 | HPLC method validation for the quantification of lomustine to study pharmacokinetics of thermosensitive liposome-encapsulated lomustine containing iohexol for CT imaging in C6 glioma rats. ( Derendorf, H; Gao, J; Li, M; Liu, C; Yu, F; Zeng, Y; Zhang, B; Zhuang, L, 2011) |
" Therefore, the pharmacokinetic properties of the CA possess a central role: iodinated x-ray CAs are small molecules that distribute rapidly within the extravascular extracellular space, whereas larger macromolecular compounds have a prolonged vascular phase and a restricted volume of distribution." | 1.39 | Dynamic contrast-enhanced computed tomography to assess antitumor treatment effects: comparison of two contrast agents with different pharmacokinetics. ( Grenacher, L; Jost, G; Pietsch, H, 2013) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 4 (80.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Shankar, JJ | 1 |
Woulfe, J | 1 |
Silva, VD | 1 |
Nguyen, TB | 1 |
Jost, G | 1 |
Pietsch, H | 1 |
Grenacher, L | 1 |
Zhuang, L | 1 |
Gao, J | 1 |
Zeng, Y | 1 |
Yu, F | 1 |
Zhang, B | 1 |
Li, M | 1 |
Derendorf, H | 1 |
Liu, C | 1 |
Yeung, TP | 1 |
Yartsev, S | 1 |
Bauman, G | 1 |
He, W | 1 |
Fainardi, E | 1 |
Lee, TY | 1 |
Stiller, W | 1 |
Kobayashi, M | 1 |
Koike, K | 1 |
Stampfl, U | 1 |
Richter, GM | 1 |
Semmler, W | 1 |
Kiessling, F | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
CT Perfusion in the Prognostication of Cerebral High Grade Glioma[NCT01923922] | 100 participants (Anticipated) | Interventional | 2013-09-30 | Recruiting | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
5 other studies available for iohexol and Glial Cell Tumors
Article | Year |
---|---|
Evaluation of perfusion CT in grading and prognostication of high-grade gliomas at diagnosis: a pilot study.
Topics: Brain Neoplasms; Cerebral Angiography; Contrast Media; Female; Glioma; Humans; Iohexol; Male; Middle | 2013 |
Dynamic contrast-enhanced computed tomography to assess antitumor treatment effects: comparison of two contrast agents with different pharmacokinetics.
Topics: Algorithms; Animals; Antineoplastic Agents; Cell Line, Tumor; Contrast Media; Gadolinium; Glioma; Io | 2013 |
HPLC method validation for the quantification of lomustine to study pharmacokinetics of thermosensitive liposome-encapsulated lomustine containing iohexol for CT imaging in C6 glioma rats.
Topics: Animals; Antineoplastic Agents; Area Under Curve; Brain Neoplasms; Calibration; Cell Line, Tumor; Ch | 2011 |
The effect of scan duration on the measurement of perfusion parameters in CT perfusion studies of brain tumors.
Topics: Brain Neoplasms; Cerebrovascular Circulation; Contrast Media; Female; Glioma; Humans; Iohexol; Male; | 2013 |
Initial Experience with a Novel Low-Dose Micro-CT System.
Topics: Animals; Coated Materials, Biocompatible; Contrast Media; Coronary Angiography; Coronary Restenosis; | 2007 |